SCHEMBL44271

SCHEMBL44271

CCN(CC)P(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9300034 0.77
SCHEMBL14126264 0.72
SCHEMBL181793 0.72
SCHEMBL10627017 0.72 CA12 (0.35)
SCHEMBL7589203 0.67
SCHEMBL5822651 0.67
SCHEMBL382993 0.67
SCHEMBL6370047 0.67
SCHEMBL8625620 0.67
SCHEMBL11842318 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6934 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3201189-A1 N-PHENYL-3-QUINAZOLIN-6-YL-BENZAMIDE DERIVATIVES AS P38 KINASE INHIBITORS Respivert Limited (GB) 2017-08-09 EP claimed
WO-2016051186-A1 N-PHENYL-3-QUINAZOLIN-6-YL-BENZAMIDE DERIVATIVES AS P38 KINASE INHIBITORS RESPIVERT LIMITED (GB) 2016-04-07 WO claimed
EP-0642526-A4 PRODUCTION OF FUCOSYLATED CARBOHYDRATES BY ENZYMATIC FUCOSYLATION SYNTHESIS OF SUGAR NUCLEOTIDES; AND IN SITU REGENERATION OF GDP-FUCOSE. SCRIPPS RESEARCH INST (US) 1996-04-10 EP claimed
EP-0642526-A1 PRODUCTION OF FUCOSYLATED CARBOHYDRATES BY ENZYMATIC FUCOSYLATION SYNTHESIS OF SUGAR NUCLEOTIDES; AND IN SITU REGENERATION OF GDP-FUCOSE THE SCRIPPS RESEARCH INSTITUTE (US) 1995-03-15 EP claimed
WO-1993008205-A1 PRODUCTION OF FUCOSYLATED CARBOHYDRATES BY ENZYMATIC FUCOSYLATION SYNTHESIS OF SUGAR NUCLEOTIDES; AND IN SITU REGENERATION OF GDP-FUCOSE THE SCRIPPS RESEARCH INSTITUTE (US) 1993-04-29 WO claimed
US-RE34069-E PROCESS FOR THE PREPARATION OF OLIGONUCLEOTIDES BIOSYNTECH GMBH (DE) 1992-09-15 US claimed
US-4725677-A USING PHOSPHINE DERIVATIVE BIOSYNTECH GMBH (DE) 1988-02-16 US claimed
JP-10210990-A None JP disclosed
US-20260146080-A1 COMPOSITION COMPRISING ANTI-GLIADIN ANTIBODIES AND METHOD OF USE THEREOF TO DETECT GLIADIN IN A SAMPLE NIMA Partners, Inc. (US) 2026-05-28 US disclosed
EP-3889611-B1 COMPOSITIONS AND METHODS FOR PERFORMING METHYLATION DETECTION ASSAYS EXACT SCIENCES CORP (US) 2026-05-27 EP disclosed
EP-4746908-A2 USE OF IL-12 RELATED BIOMARKERS AND IL-12 SPECIFIC BLOCKING ANTIBODIES FOR THE TREATMENT OF AN AUTOIMMUNE DISEASE UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2026-05-27 EP disclosed
WO-2026106907-A1 FAST PCR BY TANDEM PRIMER EMBEDDED WITH RIBONUCLEOTIDE CEPHEID (US) 2026-05-21 WO disclosed
US-20260137752-A1 SERINE PROTEINASE INHIBITORS: SERP-1 AND SERP-1 RCL-DERIVED PEPTIDES EFFECT ON MICROBIOME COMPOSITION AND USES THEREOF ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIV (US) 2026-05-21 US disclosed
EP-0229701-A2 Detection of viruses by amplification and hybridization F. HOFFMANN-LA ROCHE AG (CH) 1987-07-22 EP disclosed
EP-0217916-A1 HYBRID-GENE CASSETTE VECTOR GENE LABS, INC. (US) 1987-04-15 EP disclosed
EP-0201184-A2 Process for amplifying nucleic acid sequences F. HOFFMANN-LA ROCHE AG (CH) 1986-11-12 EP disclosed
EP-0200362-A2 Process for amplifying, detecting, and/or cloning nucleic acid sequences F. HOFFMANN-LA ROCHE AG (CH) 1986-11-05 EP disclosed
WO-1986005513-A1 HYBRID-GENE CASSETTE VECTOR GENE LABS, INC. (US) 1986-09-25 WO disclosed
EP-0173254-A1 DNA sequences of the EBV genome, recombinant DNA molecules, processes for producing EBV-related antigens, diagnostic compositions and pharmaceutical compositions containing said antigens Wolf, Hans Joachim (DE) 1986-03-05 EP disclosed
EP-0137280-A1 Recombinant fungal cellobiohydrolases CETUS ONCOLOGY CORPORATION (US) 1985-04-17 EP disclosed